Literature DB >> 4160504

Dissociation of esterolytic and clotting activities of thrombin by trypsin-binding macroglobulin.

G F Lanchantin, M L Plesset, J A Friedmann, D W Hart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4160504     DOI: 10.3181/00379727-121-30800

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  25 in total

1.  Studies on the interaction between collagen and a plasma kallikrein-like activity. Evidence for a surface-active enzyme system.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

2.  A four-straight-line model for the proteinase-binding characteristics of human blood serum.

Authors:  R M Topping; S Seilman
Journal:  Biochem J       Date:  1979-02-01       Impact factor: 3.857

3.  Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes.

Authors:  P C Harpel; M W Mosesson
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

4.  Serum protease inhibitors in the blood clearance of subtilisin A.

Authors:  M T Debanne; E Regoeczi; J Dolovich
Journal:  Br J Exp Pathol       Date:  1973-10

5.  Elevated serum trypsin binding activity in patients with hereditary pancreatitis.

Authors:  N F Adham; B Dyce; B J Haverback
Journal:  Am J Dig Dis       Date:  1968-01

6.  Evidence that antithrombin and the inhibitor of activated Stuart-Prower factor are separate entities.

Authors:  N O Osamo
Journal:  Blut       Date:  1971-11

7.  Characterization of a human serum inhibitor of Clostridium histolyticum proteinase(s).

Authors:  A Luzzati; M B Goldlust; L Levine
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

8.  Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

9.  A method for the differential determination of plasma antithrombins.

Authors:  V Musumeci; A Vincenti; B Bizzi
Journal:  J Clin Pathol       Date:  1976-01       Impact factor: 3.411

10.  Inhibitors of kallikrein in human plasma.

Authors:  D J McConnell
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.